© 2020 MJH Life Sciences and Center for Biosimilars®. All rights reserved.
© 2020 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Tony Hagen is senior managing editor for The Center for Biosimilars®.
December 01, 2020
The wearable injector has a failure rate that adds hospitalization costs; therefore, biosimilar pegfilgrastim may hold cost advantages, investigators conclude.
The Songdo district of Incheon, Republic of Korea, is rapidly becoming a major biopharmaceuticals production center.
November 30, 2020
The merger of Pfizer's Upjohn division and Mylan has created a biosimilars powerhouse with global reach.
November 28, 2020
A Shanghai Henlius Biotech study demonstrates equivalence for its bevacizumab candidate, and Celltrion moves forward with a trial for a SARS-CoV-2 candidate.